Insights

Strategic funding BioSurfaces secured a $2.06 million grant from the Gates Foundation to support development of an implant device for chronic illness, indicating strong validation and potential partner readiness for funding-backed collaborations.

GI disease focus Past collaboration with Takeda to develop GI disease treatment devices highlights established interest from large pharma in BioSurfaces nanomaterial tech for gastrointestinal applications, suggesting opportunities for co-development or licensing deals.

Innovative tech Bio-Spun proprietary nanofiber technology enables drug incorporation and localized release within medical devices and consumer products, presenting cross-market opportunities across medical devices, drug delivery, and health consumer goods.

Biopharma alignment Validated partnerships with leading pharma and life sciences organizations imply readiness for collaborations with biotech and pharmaceutical companies seeking advanced biomaterials and biocompatible textiles.

Growth potential Revenue in the mid-range multi-million dollars with a small to mid-size employee base signals agility for targeted, joint development projects, licensing, or sponsored research with faster go-to-market timelines.

BioSurfaces, LLC Tech Stack

BioSurfaces, LLC uses 8 technology products and services including Google Cloud CDN, Cart Functionality, React, and more. Explore BioSurfaces, LLC's tech stack below.

  • Google Cloud CDN
    Content Delivery Network
  • Cart Functionality
    E-commerce
  • React
    Javascript Frameworks
  • Polyfill
    Javascript Libraries
  • reCAPTCHA
    Security
  • HTTP/3
    Web & Portal Technology
  • Google Search Console
    Web Analytics
  • Facebook
    Widgets

BioSurfaces, LLC's Email Address Formats

BioSurfaces, LLC uses at least 1 format(s):
BioSurfaces, LLC Email FormatsExamplePercentage
First.Last@biosurfaces.usJohn.Doe@biosurfaces.us
96%
Last.F@biosurfaces.usDoe.J@biosurfaces.us
4%

Frequently Asked Questions

What is BioSurfaces, LLC's official website and social media links?

Minus sign iconPlus sign icon
BioSurfaces, LLC's official website is biosurfaces.us and has social profiles on LinkedIn.

What is BioSurfaces, LLC's SIC code NAICS code?

Minus sign iconPlus sign icon
BioSurfaces, LLC's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioSurfaces, LLC have currently?

Minus sign iconPlus sign icon
As of July 2026, BioSurfaces, LLC has approximately 13 employees across 1 continents, including North America. Key team members include Vice President, Business Development: G. W.. Explore BioSurfaces, LLC's employee directory with LeadIQ.

What industry does BioSurfaces, LLC belong to?

Minus sign iconPlus sign icon
BioSurfaces, LLC operates in the Biotechnology Research industry.

What technology does BioSurfaces, LLC use?

Minus sign iconPlus sign icon
BioSurfaces, LLC's tech stack includes Google Cloud CDNCart FunctionalityReactPolyfillreCAPTCHAHTTP/3Google Search ConsoleFacebook.

What is BioSurfaces, LLC's email format?

Minus sign iconPlus sign icon
BioSurfaces, LLC's email format typically follows the pattern of First.Last@biosurfaces.us. Find more BioSurfaces, LLC email formats with LeadIQ.

When was BioSurfaces, LLC founded?

Minus sign iconPlus sign icon
BioSurfaces, LLC was founded in 2003.
BioSurfaces, LLC logo

BioSurfaces, LLC

Biotechnology ResearchMassachusetts, United States11-50 Employees

BioSurfaces, LLC, based in Ashland, Massachusetts, operates within the biotechnology research sector as a small to mid-sized life sciences company. It uses a proprietary electrospinning approach to create nanofiber-based matrices that combine biological components with synthetic structures. These materials are designed for applications ranging from delivery of bio-active therapeutics to components used in medical devices and consumer health products, with the ability to form complex shapes and improved biocompatibility versus traditional textile materials. The nanofibers can incorporate drugs or other bioactive agents for localized release, and the technology is validated by leading organizations across pharmaceuticals, medical devices, life sciences, and consumer products.

The company serves customers developing pharmaceuticals, medical devices, life sciences products, and consumer health offerings that require biocompatible, functional materials. In 2017, BioSurfaces partnered with Takeda Pharmaceuticals to explore medical devices for treating gastrointestinal diseases, using its nanomaterial technology to support the collaboration.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2003
Employees
11-50

Section iconFunding & Financials

  • $10M$25M

    BioSurfaces, LLC's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    BioSurfaces, LLC's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.